Abstract:-Previous studies showed that Dalbergia sissoo exerted antimicrobial, neural, cardiac, antioxidant, antiparasitic,antidiabetic,anti-inflammatory,analgesic, Osteogenic, dermatological, gastrointestinal, reproductive and many other effects. The current review highlights the chemical constituents and pharmacological effects of Dalbergia sissoo.
III. III-PHARMACOLOGICAL EFFECTS:
Antiparasitic effect:
The petroleum ether, carbon tetrachloride, benzene and ethanol extracts of leaves of Dalbergia sissoo were assessed for anthelmintic activity against Indian earthworms (Pheretima posthuma) at different concentrations of (10, 25, 50 , and 100 mg/ml), and compared wth piperazine citrate. All the extracts revealed anthelmintic activity against the eartworms, carbon tetrachloride extract exhibited the most ptent activity with the paralysis time of 19.14±2.78 min and death time of 48.15±3.23 min at the concentration of 100 mg/ml, while piperazine citrate showed paralysis time and death time of 5.23±0.72 and 20.45±2.33 min, respectively at the concentration of 10 mg/ml [81] .
The anthelminthic activity of ethanolic extract of bark of Dalbergia sissoo was investigated against Indian earthworms Pheretima posthuma and nematode Ascardi galli. The extract was tested in various concentrations (10, 20 , 50 mg/ml) and compared with piperazine citrate (15 mg/ml) and albendazole (20 mg/ml) as standard reference and normal saline as control. The result showed that the extract of Dalbergia sissoo possessed strong anthelminthic activity [82] .Adult immersion test was employed to study the acaricidal activity of leaf extracts of Dalbergia sissoo against resistant ticks. Mortality and fecundity of ticks exposed to leaf aqueous (SLA) and ethanolic (SLE) extracts were evaluated at concentrations of 0.625, 1.25, 2.5, 5.0 and 10.0% and controls (distilled water and 10% ethanol). Higher acaricidal activity was recorded in SLA with a lower LC 50 (95% CL) value of 1.58% (0.92-2.71%) than SLE [5.25% (4.91-5.63%)]. A significant decrease in egg mass weight and reproductive index was recorded in treated ticks along with an increase in percent inhibition of oviposition. A complete inhibition of hatching was recorded in eggs laid by ticks treated with higher concentrations of SLA, whereas, SLE exhibited no effect on hatching percentage [83] .The molluscicidal effects of the crude aqueous and ethanolic extracts of Dalbergia sissoo fruits, leaves, roots and stem bark were studied against egg masses of Biomphalaria pfeifferi, the snail intermediate host of Schistosoma mansoni in Nigeria. Viable 0-24 hr-old embryonated egg masses were separately exposed to five different concentrations (7.81-2000 mg/l) of extracts for 24 hrs, washed in dechlorinated tap water and incubated at room temperature for a maximum of 4 weeks. The LC 50 and LC 90 values of the tested extracts for egg masses were calculated by probit analysis. The activities of the tested extracts were concentration-dependent. However, only the ethanolic extract of the fruits demonstrated significant activity (24 hr-LC 90 value < 100 mg/l: 89.29 mg/l). Mortalities of eggs were manifested at the gastrula/exogastrula and or the prehatch snail stage of development. The percentage of dead embryos at the prehatch snail stage decreased while the deaths of embryos at the gastrula/exogastrula stage increased, with increasing concentration of extract [84] . The larvicidal, growth inhibitor and repellent actions of Dalbergia sissoo oil was studied against Anopheles stephensi, Aedes aegypri and Culex quinquefasciacus. Pure oil was applied at 0.4-5ml/m 2 on a water surface. This showed larvicidal activity directly proportional to dosages. One hundred percent mortality of immature Culex quinquefasciacus was observed within 24 hrs at 4ml/m 2 , followed by Anopheles stephensi (60%), and pupation was totally inhibited. The oil also showed strong repellent action when 1ml oil was applied on exposed parts of human volunteers. They were protected from mosquito bites for 8-11h. The protection (91.6±2%) was recorded with Dalbergia sissoo oil as compared to that with commercial available Mylol oil (93±1.2%) consisiting of di-butyl and dimethyl phthalates [85] .
Antiinflammatory and analgesic effects:
The anti-inflammatory activity of hexane and methanol extracts of Dalbergia sisso and okanin was evaluated by carrageenan induced paw oedema in rats. The methanolic extract showed maximum activity [70] . The antiinflammatory activity of a 90% ethanolic extract of Dalbergia sissoo bark was studied using a right hind paw oedema method in Wistar rats. After oral administration of ethanolic extract at different doses (300, 500 and 1000 mg/kg), inhibition of right hind paw oedema was observed at 30, 60, and 120 min time intervals. The antiinflammatory effects increased with increasing doses. The ethanolic extract of Dalbergia sissoo bark at 1000 mg/kg showed the most potent anti-inflammatory activity compared to the other doses (300 and 500 mg/kg) throughout the observation period [64] .The analgesic and anti-inflammatory properties of the methanolic extract of leaves of Dalbergia sissoo were evaluated by using acetic acid induced writhing and hot plate tests in mice and carrageenan-induced paw oedema in rats. Oral pretreatment with the leaves extracts of Dalbergia sissoo significantly decreased the writhing movements in mice in acetic acid-induced writhing test and significantly increase the mean pain latency time in mice placed on the hot plate at 50°C at dose dependant manner. In the carrageenan-induced paw oedema model, the methanolic extract afforded 68.2% inhibition of hind paw oedema in rats at the highest dose (600 mg/kg) compared to 73.4% inhibition obtained with the reference drug, diclofenac (5 mg/kg) at the third hour after carrageenan administration [86] .The alcoholic extract of Dalbergia sissoo seeds was evaluated for analgesic and antipyretic activities. The peripheral analgesic activity of seed extract was studied using acetic acid-induced writhing in mice and by Randall-Selitto assay in rats. Furthermore, the central analgesic activity of seeds extract was studied by tail-clip test and hot plate method in mice. The antipyretic activity of seeds extract was studied in Brewer's yeast-induced pyrexia in rats. The alcoholic extract of Dalbergia sissoo seeds was significantly decreased writhing movements of acetic acid-induced writhing in mice, and significantly increased the pain threshold capacity in rats in Randall-Selitto assay and the reaction time in hot-plate test but not in tail-clip test. Moreover, it also showed significant antipyretic activity in Brewer's yeast-induced pyrexia in rats throughout the observation period of 6 h [87] . The analgesic activity of the ethanol extract of the bark of Dalbergia sissoo was investigated using the tail flick method in Wistar rats. The extract at the doses of 300, 500 and 1000 mg/kg possessed significant and dose dependent, central analgesic activity, compared with the standard drug aspirin at the dose of 300 mg/kg. An ethanol extract of the leaves of Dalbergia sissoo showed both peripheral and central analgesic activity in a dose dependent manner. Peripheral analgesic activity was studied using the acetic acid-induced writhing reflex and Randall-Selitto assays in mice, while, central analgesic activity was studied using the hot-plate and tail-clip tests in mice. In writhing test, the extract (100, 300 and 1000 mg/kg) moderately inhibited writhing in mice, in Randall-Selitto assay, the extract failed to increase pain threshold level at the doses of 100 and 300 mg/kg but exhibited significant (P< 0.01) activity at the dose of 1000 mg/kg, the extract (1000 mg/kg) increased reaction time at 2 and 3 h while pathidine (5mg/kg) increased reaction time at 1 and 2 h. The ethanol extract of the leaves of Dalbergia sissoo showed significant antipyretic activity in a Brewer's yeast-induced pyrexia assay in rats. The extract at the doses of 100 and 300 mg/kg showed significant antipyretic activity at 1 h after drug administration while at the 1000 mg/kg, it showed activity throughout the observation period up to 6 h and the effect was comparable to aspirin (300 mg/kg) [88] [89] .The analgesic potential of the ethanolic bark extract of Dalbergia sissoo bark was measured by the Radiant Heat method (tail flick method). The bark extract showed significant analgesic activity as evidenced by the increase in reaction time to the pain stimulus. The extract 300 and 500 mg/kg failed to alter pain threshold capacity but, it increased significantly at the dose of 1000 mg/kg at 30 min [67] . The antinociceptive activity of ethanolic extract of the plant bark of Dalbergia sissoo was investigated using tail flick method on Wistar rats. Three different dose levels (300, 500, and 1000 mg/kg) in 0.5% carboxyl methyl cellulose were administered orally. At these doses, the extract exhibited significant and dose-dependent antinociceptive activity [66] .
Antidiabetic effect:
The ethanol, ethyl acetate, n-butanol and petroleum ether extracts of the leaves of Dalbergia sissoo were investigated for antidiabetic activity in alloxan induced diabetic rats. The extracts produced a significant antidiabetic effect on first, third, fifth and seventh days at 300 mg/Kg body weight. Among all the extracts of Dalbergia sissoo, ethanol extract of leaves exhibited highly significant antidiabetic activity which was comparable with the standard drug, Glibenclamide [90] . The hypoglycemic effect of ethanolic extract of Dalbergia sissoo leaves was evaluated in alloxanized diabetic rats. The ethanolic extract of Dalbergia sissoo leaves was administered orally at different doses (250 and 500 mg/kg) to normal rats. The dose of 500 mg/kg was found to be more effective in oral route and it decreases blood glucose level (BGL) by 38.2 % in normal healthy rats after 1 day of administration. After daily treatment with the both doses (250 and 500 mg/kg) of ethanolic Dalbergia sissoo extract for 21 days to severely diabetic (FBG 300-350 mg/dl) rats, the BGL reduced to 125 mg/dl by 250 mg/kg and to 104 mg/dl by 500 mg/kg. It was more effective when compare with the standard drug glibenclamide. It reduced blood glucose level up to 189.2, 115.2, 104.6 mg/dl at successive days of 7, 14, 21, at the dose of 500 mg/kg compare with standard drug which reduces blood glucose level up to 250.2, 141.2, 120.4 mg/dl. In comparison to glibenclamide, the extract was 12% more effective in reducing blood glucose level [91] .The antidiabetic potential of alcoholic and aqueous stem bark extract of Dalbergia sissoo and their fractions was studied on streptozotocin-nicotinamide induced type 2 diabetic rats. The study also included estimations of blood glucose levels, lipid profile, liver glycogen, body weight and antioxidant status in normal and diabetic rats. The results showed that alchohalic extracts (250 and 500mg/kg) and aqueous extract (400mg/kg) significantly reduced the blood glucose level (P< 0.05), whereas hexane soluble extracts and butane soluble extract did not reduce the blood glucose level significantly. Alcoholic and aqueous extracts significantly restored the lipid profile and showed improvement in liver glycogen, body weight and antioxidant status in diabetic rats [92] . The antidiabetic effect of ethanolic extract of Dalbergia sissoo bark (250 and 500 mg/kg) was investigated in alloxan induced diabetic rats. The two doses caused significant reduction in blood glucose levels. The effect was more pronounced in 500mg/kg than 250 mg/kg. Dalbergia sissoo also caused significant increase in body weight and glycogen content in liver of alloxan -induced diabetic rats while there was significant reduction in the levels of serum triglyceride and total cholesterol. Dalbergia sissoo also caused significant improvement in the pancreas of alloxan -induced diabetic rats [93] .
Dermatological effects:
The cytotoxicity and in vitro melanogenic activity on bark of Dalbergia sissoo were studied. The various successive bark extracts have been individually evaluated for trials of spontaneous melanin content, and cell viability by the MTT assay in murine B16F10 melanoma cells in vitro. Based on the percentage of cell viability assay, graded concentration of extracts were taken for in vitro melanogenic activity. The result indicated that ethyl acetate extract of bark of Dalbergia sissoo was non-toxic and increased melanin activity as compared to hexane and ethanol extracts. The authors concluded that the bark of Dalbergia sissoo stimulates B16F10 melanogenesis at very low concentrations which support the folk medicinal use of Dalbergia sissoo in the treatment of hypopigmentation diseases, such as vitiligo [94] .
Osteogenic effects:
The effect of Dalbergiphenol (DGP), the neoflavonoid isolated from heartwood was evaluated in bone loss in ovariectomized mice. Adult BALB/c mice were ovariectomized and administered DGP (1 and 5 mg/kg/d) or 17β-estradiol (E2) orally for 6 weeks. The sham group and the ovariectomy (OVX) + vehicle group served as controls. Uterine estrogenicity, bone microarchitecture, biomechanical strength, new bone formation (based on bone formation rate and mineral apposition rate), and skeletal expression of osteogenic and resorptive gene markers were studied. The sham group and the ovariectomy (OVX) showed marked increase in body weight and a decrease in femoral and vertebral trabecular bone volume that were prevented by DGP or E2 treatment. DGP treatment increased bone biomechanical strength and new bone formation rate in ovariectomized mice, comparable with E2 treatment. However, increase in uterine weight and estrogenicity were observed in E2-treated ovariectomized mice, but not in response to DGP treatment. Treatment with DGP increased messenger RNA expression of runt-related transcription factor 2, osterix, and collagen type I, and decreased messenger RNA expression of tartrate-resistant acid phosphatase and the osteoprotegerin-to-receptor activator of nuclear factor-κB ligand ratio in the femur of ovariectomized mice. The authors concluded that DGP treatment can effectively prevent OVX-induced increase in bone loss and decrease in bone strength possibly by increasing osteoblastic activities and by decreasing osteoclastic activities [95] .
The skeletal effects of an extract made from the leaves and pods of Dalbergia sissoo (butanol-soluble standardized fraction [BSSF]) was studied in ovariectomized rats, a model for postmenopausal osteopenia. In comparison with ovariectomized rats treated with vehicle, BSSF treatment in improved trabecular microarchitecture of the long bones, increased biomechanical strength parameters of the vertebra and femur, decreased bone turnover markers (osteocalcin and type I collagen) and expression of skeletal osteoclastogenic genes, and increased new bone formation and expression of osteogenic genes in the femur. Overall, the osteoprotective effects of BSSF were comparable to those of 17β-estradiol [96] .
The new isoflavone glucoside, caviunin 7-O-[β-D-apiofuranosyl-(1→6)-β-D-glucopyranoside] and four known compounds namely genstein, biochanin A, pratensein and biochanin 7-O-glucoside, isolated from the leaves of Dalbergia sissoo, showed osteogenic activity in primary calvarial osteoblast cultures. These compounds showed increased alkaline phosphatase activity and mineralization, which substantiated potential osteogenic activity. The compounds at the concentrations ranging from 1 pM to 1 μM were applied to calvarial osteoblast cells to screen alkaline phosphatase activity as well as stimulatory activity on osteoblast formation mediated via estrogen receptor (ER). It was found that differentiation of osteoblast formation was ER independent. [75] .
The leaves and pods extract of Dalbergia sissoo showed antiresorptive and bone-forming effects. The positive skeletal effect attributed to active molecules present in the extract of Dalbergia sissoo.
, a novel isoflavonoid found in high percentage in the extract was studied as an alternative for anabolic therapy for the treatment of osteoporosis by stimulating bone morphogenetic protein 2 (BMP2) and Wnt/β-catenin mechanism. CAFG supplementation improved trabecular micro-architecture of the long bones, increased biomechanical strength parameters of the vertebra and femur and decreased bone turnover markers better than genistein. Oral administration of CAFG to osteopenic ovariectomized mice increased osteoprogenitor cells in the bone marrow and increased the expression of osteogenic genes in femur and showed new bone formation without uterine hyperplasia. CAFG increased mRNA expression of osteoprotegerin in bone and inhibited osteoclast activation by inhibiting the expression of skeletal osteoclastogenic genes. CAFG was also an effective accelerant for chondrogenesis and has stimulatory effect on the repair of cortical bone after drill-hole injury at the tissue, cell and gene level in mouse femur. At cellular levels, CAFG stimulated osteoblast proliferation, survival and differentiation. Signal transduction inhibitors in osteoblast demonstrated involvement of p-38 mitogen-activated protein kinase pathway stimulated by BMP2 to initiate Wnt/β-catenin signaling to reduce phosphorylation of GSK3-β and subsequent nuclear accumulation of β-catenin. Osteogenic effects were abrogated by Dkk1, Wnt-receptor blocker and FH535, inhibitor of TCF-complex by reduction in β-catenin levels. CAFG modulated MSC responsiveness to BMP2, which promoted osteoblast differentiation via Wnt/β-catenin mechanism. CAFG at 1 mg/kg/day dose in ovariectomy mice (human dose ∼0.081 mg/kg) led to enhanced bone formation, reduced bone resorption and bone turnover better than well-known phytoestrogen genistein. Accordingly , it could be positioned as a potential drug, food supplement, for postmenopausal osteoporosis and fracture repair [97] .
Antimicrobial effect:
The methanol, hexane extracts and isolated okanin from methanol extracts were exhibited good antibacterial activity towards various pathogens, Gram positive (Micrococcus luteus and Staphlcocous aureus) and Gram negative bacteria (Escherichia coli, R. planticola and Acinetobacter) [70] . 1,2-benzenedicarboxylic acid dibutyl ester (13.68%) and 5-nirto-2,4 (1H,3H)-pyrimidine dione isolated from the plant, showed antibacterial activity against Staph aureus, Bacillus cereus, Serratia marcescens and Proteus mirabilis [69] .
A herbal preparation containing Dalbergia sissoo and Datura stramoium was evaluated for its antibacterial potential against pathogenic strains of Gram positive (Staphylococcus aureus and Streptococcus pneumoniae) and Gram negative (Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae) bacteria. The extracted fractions of the herbal preparation were found active against both Gram positive as well as Gram negative bacteria. Gram positive bacteria showed higher sensitivity [98] . Dalbergia sisso was evaluated for its antibacterial potential against eight human pathogenic bacterial strains. Triple maceration method was adopted for the methanolic extraction of whole plant and leaves. In vitro, antimicrobial test was performed by disc diffusion method. Whole plant's extract showed good antibacterial activity against S. aureus (18.00mm), S. pneumoniae (17.50mm) Modified agar well diffusion method was used to measure the minimum inhibitory concentration.MIC values of the whole plant extract lies within the range of 75 to 300 μg /ml for the Gram positive strains while 75 to 600 μg /ml for Gram negative strains [99] .
Antioxidant effect:
Extract of bark of Dalbergia sissoo Roxb (Fabaceae) was assessed for its antioxidant activity by in vitro methods. Antioxidant activity was studied using hydrogen peroxide scavenging activity and reducing power assay. The extracts exhibited significant antioxidant activity [100] . The ethanol extract of the bark of Dalbergia sissoo was screened for lipid peroxidation inhibitory (LPO). The bark extract showed 69.1% LPO inhibitory potential/10 μg of extract [80] . The antioxidant activity of the aqueous and methanol extracts of the stem bark of Dalbergia sissoo was evaluated by 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity, ferric ion reducing power, ferrous ion chelating activity and Au nanoparticle formation potential. In all the assays, aqueous extract showed significantly greater activity than methanol extracts [101] .
The in vitro antioxidant activity of the successive petroleum ether, chloroform and methanol extracts of the stem bark of Dalbergia sissoo was investigated through DPPH free radical scavenging activity, reducing power, FRAP (ferric reducing antioxidant power) assay, ferrous ion scavenging activity and nitric oxide (NO) radical scavenging activity. Among different extracts, the chloroform extract was found to be most potent showing the IC 50 of 25 μg/ml for DPPH model, 21μg/ml for reducing power, 26 μg/ml for ferrous ion scavenging, 26 μg/ml for FRAP assay and 25 μg/ml for NO scavenging activity, which were comparable to positive control (ascorbic acid). The activity of petroleum ether and methanol extract was found to be moderate. Total phenolic contents of the various extracts were estimated as 50.8 mg/g. Strong positive correlation was recorded between the antioxidant activity and total phenolic content of the different extracts [79] .
Antioxidant activity of methanolic extract of Dalbergia sissoo root was investigated for its free radical scavenging activity by determining the nitric oxide and hydrogen peroxide scavenging activity. Maximum scavenging of nitric oxide and hydrogen peroxide were 26.66% and 50.68% respectively at 250 μg/ml concentration. The results were compared with rutin as a standard [102] . Three water-soluble polysaccharides were isolated and purified from the leaves of Dalbergia sissoo. Antioxidant and moisture preserving activities of these three polysaccharides were investigated using in vitro methods. The antioxidant activities studied including testing of superoxide O 2-, 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS, hydroxyl OH -, nitric oxide (NO), N,N-dimethyl-pphenylenediamine (DMPD) radical scavenging activities, ferric ion Fe 3+ reducing ability, ferrous ion (Fe 2+ ) chelating and lipid peroxidation activities. The result revealed water-soluble polysaccharides possessed antioxidant characteristics. Furthermore, the polysaccharides showed effective moisture retention properties in comparison with hyaluronic acid and glycerol [71] .
Many constituents, also isolated from other species (D. odorifera) included 4,2ʹ,5ʹ-trihydroxy-4ʹ-methoxychalcone, (2S)-6,4ʹ-dihydroxy-7-methoxyflavan, 6,4ʹ-dihydroxy-7-methoxyflavanone, R(+)-4-methoxydalbergione, R(-)-latifolin, R(+)-dalbergiphenol, 9-hydroxy-6,7-dimethoxydalbergiquinol and isoparvifuran showed a protective effect on glutamate-induced oxidative injury in HT22 cells. All compounds were tested at the concentrations of 1, 10, 20 and 50 μM and compared with trolox (positive control). EC 50 values were of 7.47, 2.85, 3.3, 8.54, 5.82, 6.54, 8.14 and 3.09 μM, for these compounds respectively in comparison with trolox which showed EC50 value of 15.8 μM [103] .
Antiulcer effect:
The antiulcer effects of Dalbergia sissoo stem bark methanol extract (DSME) was studied against the diclofenac sodium-induced ulceration in rat. The DSME (200 and 400 mg/kg body weight) was orally administered to rats once a day for 10 days in diclofenac-treated rats. The gastroprotective effects of DSME were determined by assessing gastric-secretory parameters such as volume of gastric juice, pH, free acidity, and total acidity. Biochemical studies of gastric mucosa were conducted to estimate the levels of nonprotein sulfhydryls (NP-SHs), lipid peroxidation [thiobarbituric acid reactive substances (TBARSs)], reduced glutathione (GSH), hydrogen peroxide (H 2 O 2 ), levels of scavenging antioxidants, catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), glutathione-S-transferase (GST), and myeloperoxidase (MPO). Moreover, adherent mucus content and histological studies were performed on stomach tissues. Administration of DSME significantly decreased the ulcer index, TBARSs, H 2 O 2 , and MPO activity in gastric mucosa of the ulcerated rats. Activities of enzymic antioxidants, CAT, SOD, GSH-Px, GST and GSH, and NP-SH contents were significantly increased with DSME treatment in diclofenac-treated rats. Volume of gastric juice, total and free acidity were decreased, whereas pH of the gastric juice was increased with the administration of DSME + diclofenac [104] . The antiulcer activity of crude ethanolic bark extract of Dalbergia sissoo(EBED) was evaluated using pylorus ligation and indomethacin induced ulcer model in Wistar albino rats. The study revealed significant decrease (P< 0.01) in mean ulcer index in EBED treated group in both models compared to control. Furthermore, there were significant decrease (P< 0.01 and P< 0.001) in the offensive factors like free and total acidity, pepsin content and protein content, with a significant increase in the defensive factors like total carbohydrate content (P< 0.01) and ratio of total carbohydrates and proteins as compared to control in dose dependent manner [105] .
Antidiarrhoeal effect:
The ether, ethanol, and aqueous extracts of Dalberjia sissoo bark were studied for anti-diarrhoeal properties in experimental diarrhea, induced by castor oil in rats at te dose of 200 -400 mg/kg orally, the ether extract showed significant and dose dependent anti-diarrhoeal activity. The extracts also significantly reduced the intestinal transit time in charcoal meal when compared with atropine sulphate (1 mg/kg ip) The ether extract was found to be equipotent to atropine [106] [107] . The protective effect of ethanol extract from Dalbergia sissoo leaves (EDSL) was studied in experimentally induced diarrhoea and peristalsis in mice. Castor oil-induced diarrhoea and magnesium sulphate (MgSO 4 )-induced diarrhoea tests were used to assess the antidiarrhoeal activity of Dalbergia sissoo. Gastrointestinal tract transit of charcoal meal test and barium sulphate milk was used to assess the peristalsis activity of the extract. The EDSL significantly reduced faecal output in castor oilinduced and MgSO4-induced diarrhoea and also significantly reduced the number of diarrhoeal episodes. Dalbergia sissoo significantly delayed the onset of diarrhoea induced by both castor oil and MgSO 4 comparable to loperamide, a standard antidiarrhoeal drug. Both Dalbergia sissoo and atropine sulphate significantly reduced the peristalsis activity of charcoal meal and barium sulphate milk in mice [108] .The effect of a decoction of dried leaves of Dalbergia sissoo was evaluated in diarrhea. Antibacterial, antiprotozoal, and antiviral activities of the plant decoction were checked by agar dilution method, tube dilution method, and neutral red uptake assay, respectively. Cholera toxin and Escherichia coli labile toxin (LT) were assayed by ganglioside monosialic acid receptor. Suckling mouse assay was used to assess E. coli stable toxin (ST). As a measure of colonisation, the effect against adherence of E. coli and invasion of E. coli and Shigella flexneri to HEp-2 cells were studied. The decoction had no antibacterial, antiprotozoal, and antiviral activity. It inhibited the production of cholera toxin, and increased the production of labile toxin. Binding of both LT and CT to the GM1 receptor was reduced [68] .
Cardiac effect:
The effect of alcoholic extract of Dalbergia sissoo leaf extract (DSE) (30, 100 and 300 mg/kg of body weight) was studied in isoproterenol (ISP)-induced myocardial injury in rats. Assessment of myocardial injury was done by estimation of different cardiac injury markers like LDH, CK-MB. Serum cholesterol, LDL, HDL, triglycerides in serum, myocardial infarcted area, oxidative stress and histopathology of heart tissue in rats. Mean arterial pressure and heart rate were recorded in all the groups. Rats pretreated with DSE (30, 100 and 300 mg/kg of body weight) showed significant (P< 0.05-0.001) improvement in the relative heart weight, myocardial infarcted areas, heart rate and mean arterial pressure in ISP-induced myocardial injury. DSE showed significant (P< 0.05-0.001) improvement in serum LDH, CK-MB, cholesterol, LDL and triglyceride levels at all the dose levels. However, DSE pretreatment had no significant effect on serum HDL level. Pretreatment with DSE (30, 100 and 300 mg/kg body weight) showed significant (P< 0.001) reduction in MDA level in comparison with myocardial injured rats. Furthermore, antioxidant potential was also improved in terms of improved activities of reduced glutathione, superoxide dismutase and catalase with the DSE pretreatment. Histopathology also showed significant improvement in heart tissue [109] .
CNS effects:
The effect of ethanolic leaf extracts of Dalbergia sissoo (ELDS) on learning and memory activity was evaluated in mice. ELDS was given as 300, 450 and 600 mg/Kg respectively. The effect of ethanolic leaf extract of Dalbergia sissoo was investigated in mice for memory enhancing activity using various experimental paradigms of learning and memory (Transfer latency (TL) on elevated plus maze and passive avoidance). For memory and learning activity vehicle/ extracts / STD drug administered daily for first seven days, on 8 th day dementia was induced by scopolamine. ELDS significantly enhanced the learning and memory activities against the scopolamine induced dementia and significant decrease in acetylcholinesterase level in brain in animals. The memory enhancement activity was due to cholinergic facilitatory effect in animals [110] . The neuroprotective effects of the ethanolic extract of Dalbergia sissoo leaves was evaluated by checking brain weight, antioxidant levels, histopathological and TTC staining studies in cerebral ischemia induced in rats. The ethanolic extracts was given at 300, 600 mg/kg and were compared to negative control (global cerebral ischemic rats). It was observed that prior treatment with Dalbergia sissoo extract (300mg/kg and 600mg/kg, po for 10days) markedly reversed the brain weight, antioxidant levels and restored to normal levels as compared to ischemia-reperfusion induced oxidative stress groups. Moreover, brain coronal sections staining and histopathological studies revealed protection against ischemic brain damage in the extract treated groups [111] . The neuroprotective effect of ethanolic extract of Dalbergia sissoo leaves was evaluated in 3-nitropropionic acid induced neurotoxic rats. The ethanolic extract of Dalbergia sissoo leaves was administered orally at different doses (300 and 600 mg/kg) to neurotoxic rats. During treatment psychopharmacological parameters were recorded, and 24 hours after experiment antioxidant profiles from brain isolates were estimated and histopathology of brain was performed. The ethanolic extract significantly attenuated behavioral alterations, oxidative damage, mitochondrial dysfunction, and striatal/hippocampus damage in 3-nitropropionic acid treated rats [112] .
Reproductive effect:
The anti-spermatogenic efficacy of ethanol extract of stem bark of Dalbergia sissoo was evaluated in healthy fertile men. Semen samples were obtained from 15 healthy fertile men aged 25-35 years. Sperm motility was examined by the Sander-Cramer method. A dose-dependent and time-dependent effect of ethanol extract on sperm motility and sperm viability were observed. Various concentrations affected the motility of sperm. Ethanol extract at a concentration of 20 mg/ml caused complete immobilization within 3 minutes. Sperm viability and hypo-osmotic swelling was significantly reduced at this concentration. An in vivo antifertility studies were carried out on Swiss male albino mice. Ethanol extract at a dose of 200 mg/kg body weight resulted in a significant decrease (P< 0.001) in weight of the testis and epididymis. A significant decrease (P< 0.01) in sperm motility and sperm count in the epididymis were observed. Histopathological changes in the epididymis and testis were also recorded [113] .
Antifertility effects of Dalbergia sissoo was investigated in male mice. Adult Parkes strain male mice were orally administered aqueous leaf extract of Dalbergia sissoo (50 and 100 mg/kg body weight/day) for 35 days. Motility, viability and number of spermatozoa in the cauda epididymidis; testis histology; serum level of testosterone; and toxicological effects were evaluated. To assess reversibility, mice were treated with 100 mg/kg body weight of Dalbergia sissoo or distilled water for 35 days and sacrificed 56 days later. The fertility parameters were also assessed separately. Histologically, testes of Dalbergia sissoo -treated mice showed dissimilar degenerative changes in the seminiferous tubules. Significant reductions were noted (i) in epididymal sperm motility, viability and number, and (ii) in serum level of testosterone in Dalbergia sissoo -treated mice compared to controls. However, serum levels of alanine aminotransferase, aspartate aminotransferase and creatinine, and haematological parameters were not affected. Libido in Dalbergia sissoo -treated males showed no change, but their fertility was markedly suppressed. By 56 days of treatment withdrawal, the alterations induced in fertility parameters were returned to control levels [114] .
Toxicity:
The acute toxicity study showed that the ethanol bark extract of Dalbergia sissoo was nontoxic up to 3000 mg/kg body weight in Swiss albino mice [66] .Acute toxicity studies were carried out on Wistar rats. Alcohalic bark extracts at dose of 50, 100, 300, 1000, and 3000 mg/kg body weight were administered after over night fasting. Acute toxicity studies did not reveal any toxic symptoms or death in any of the animal up to the dose level 3000 mg/kg boy weight [67] . 90% ethanolic extract was also safe up to 3000 mg/kg, orally in the rats [64] .
IV. DOSE
1.5-10g powder and 10-20 g for decoction [58] .
V. CONCLUSION
The review discussed the chemical constituents, pharmacological effects and therapeutic importance of Dalbergia sissoo as promising herbal drug because of its safety and effectiveness.
